A new drug, apitegromab, is showing promise in preserving lean muscle mass for individuals undergoing significant weight loss, particularly those using popular 'slimming jabs' like tirzepatide.
News Raise
Lessons from the tobacco industry's playbook on addiction and marketing are being applied to understand and potentially combat the widespread consumption of ultra-processed foods.
Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.
Rivian has commenced deliveries of its highly anticipated R2 SUV, a model seen as pivotal for the electric vehicle manufacturer's future growth and market positioning.
SpaceX's potential Initial Public Offering is reportedly experiencing significant investor interest, with demand approaching four times the number of shares available, according to a source familiar with the matter.
Major U.S. stock indices, including the S&P 500 and Nasdaq, closed lower as an anticipated rebound in semiconductor stocks failed to materialize, contributing to a broader market downturn.
AMD anticipates that DDR5 memory prices will not normalize until 2028, citing the significant demand from the artificial intelligence sector that is currently impacting consumer supply.
Reports indicate that Apple's recently developed artificial intelligence models do not utilize or incorporate any aspects of Google's Gemini Assistant technology.
Apple announced significant advancements in its AI capabilities at WWDC 2026, including a revamped Siri, the next iteration of its operating system iOS 27, and an expanded suite of features under the Apple Intelligence umbrella.
Astronauts aboard the International Space Station (ISS) briefly relocated to a "safe haven" module following concerns over a coolant leak. NASA has since provided an update, and the situation appears to be under control.









